Lin Wei

Lin Wei (senior executive) discloses dealings in 3 companies, chiefly Revolution Medicines, Inc., 2seventy bio, Inc. and Erasca, Inc. Over a trading history stretching from 1 February 2022 to 17 March 2026, the count stands at 12 filings.

On the market, this insider has only sold: 4 sales, €532k in total. The rest of the record consists of 5 share grants. Since January 2026: no purchases and 1 sale on the market.

The latest filing, published on 19 March 2026, reports an open-market sale of €179k in Revolution Medicines, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.